News | June 02, 2015

Cincinnati Children’s Hospital Sees Potential of Synthetic MRI for Pediatrics

Technology creates multiple diagnostic sequences from a single acquisition, which could shorten exam time

SyMRI, Cincinnati, CCHMC, synthetic MRI, pediatrics

Image courtesy of SyntheticMR AB


June 2, 2015 — Cincinnati Children’s Hospital Medical Center (CCHMC) has evaluated synthetic magnetic resonance imaging (MRI) on pediatric cases to study and clinically validate its use on children. Results from the first part of the evaluation, which used SyMRI software, shows the synthetic images are diagnostically satisfactory in comparison with conventional sequences.

Long examination times are particularly challenging when examining children, who may even need to be given a general anesthetic during the exam. A faster workflow would therefore be especially valuable for pediatric applications. CCHMC sees an opportunity to improve the efficiency of pediatric MRI by being able to shorten the examination time with SyMRI. Synthetic imaging is being evaluated on pediatric cases at CCHMC in two steps. At first it has been ensured that the synthetic images are diagnostically sufficient in comparison with conventional sequences.

SyntheticMR AB develops and markets new MRI software solutions. It created the SyMRI Image software that provides fast MRI workflows, allowing high patient throughput, and SyMRI Neuro that enables automatic segmentation of brain tissue, providing objective decision support based on quantitative data. SyMRI is a CE-marked product. A customized version of SyMRI Image was introduced at the 2014 Radiological Society of North America (RSNA) annual meeting by SyntheticMR’s strategic partner GE Healthcare under the name MAGiC for GE’s line of Signa MRI systems.

“Because of the way the brain develops, a true strength of synthetic imaging that could be particularly useful in pediatric cases is the possibility of tuning image contrast afterwards and generating contrasts that usually are not acquired. Therefore the use of synthetic imaging, including interactive contrast changes during review, is now ongoing as the second step of evaluation. The ability to create multiple diagnostic sequences from a single acquisition may allow for substantial time savings and increased throughput”, said Blaise V. Jones, M.D., chief of neuroradiology, Cincinnati Children’s Hospital Medical Center.

While clinical validation of synthetic MRI relative to standard pulse sequences has been performed in adults, no such data has previously been available on children. The study at CCHMC evaluates synthetic MRI in children by comparing synthetic MR images with conventional MR images in children at both 1.5 and 3.0T in a blinded fashion to determine image quality and diagnostic efficacy relative to standard MRI.

“We see great potential for its use in clinical practice, and anticipate that synthetic imaging is going to help us discern subtle differences at grey matter to white matter interfaces, for example in epilepsy cases. Furthermore we expect that the quantitative T1, T2 and PD maps can assist us in monitoring the myelination process of white matter during the first years of brain development”, Jones continued.

SyMRI IMAGE from SyntheticMR optimizes the MRI workflow and shortens scan time using synthetic MRI. This is achieved by a single MR quantification scan of 5-7 minutes. Based on this single scan, conventional standard T1W, T2W and FLAIR images and any other combination of TE, TR and TI can be shown without rescanning the patient, allowing a substantial reduction in examination time.

For more information: www.symri.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Nov. 21, 2024 — Royal Philips plans to unveil its next-generation 1.5T BlueSeal MR wide-bore scanner at RSNA 2024 in ...

Home November 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Home February 21, 2024
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2023 — Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy ...

Home November 17, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 28, 2023 — Liver disease, the UK’s third leading cause of premature death, poses a significantly greater threat to ...

Home June 28, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 20, 2023 — The US Food and Drug Administration has approved the use of iTFlow in blood flow analysis. The FDA ...

Home June 20, 2023
Home
News | Magnetic Resonance Imaging (MRI)

June 7, 2023 — GE HealthCare announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based ...

Home June 07, 2023
Home
Feature | Magnetic Resonance Imaging (MRI) | By Johnson Polakkal Joseph

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in ...

Home May 01, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...

Home April 18, 2023
Home
News | Magnetic Resonance Imaging (MRI)

April 4, 2023 — Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of ...

Home April 04, 2023
Home
News | Magnetic Resonance Imaging (MRI)

November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in ...

Home November 17, 2022
Home
Subscribe Now